Krishna Institute of Medical Sciences working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

36.30×	36.30×	33.03×	31.77×	32.55×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
44.38×	44.38×	41.48×	39.96×	41.96×
133.54×	133.54×	135.73×	127.82×	115.35×
−52.86×	−52.86×	−61.22×	−56.09×	−40.84×
−13.97×	−12.95×	−21.85×	17.76×	12.13×
0.58×	0.58×	0.63×	0.74×	1.14×
2.11×	2.11×	1.40×	1.55×	1.18×
0.64×	0.64×	0.74×	0.81×	0.72×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

KIMS₹702.50

Krishna Institute of Medical Sciences Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS JUBLPHARMA INDGN ONESOURCE PFIZER POLYMEDMcap ₹28,100 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Inventory Days (DIO)	32.55	31.77	33.03	36.30	36.30
Receivable Days (DSO)	41.96	39.96	41.48	44.38	44.38
Payable Days (DPO)	115.35	127.82	135.73	133.54	133.54
Cash Conversion Cycle (days)	-40.84	-56.09	-61.22	-52.86	-52.86
Working Capital Turnover	12.13	17.76	-21.85	-12.95	-13.97
Asset Turnover	1.14	0.74	0.63	0.58	0.58
Cash Conversion (CFO/Net Income)	1.18	1.55	1.40	2.11	2.11
CFO/EBITDA	0.72	0.81	0.74	0.64	0.64

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.